Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
TypePrivate
HQAustin, US
Founded2006
Size (employees)273 (est)+3%
Websiteapolloendo.com
Apollo Endosurgery was founded in 2006 and is headquartered in Austin, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Apollo Endosurgery

Todd Newton

Todd Newton

CEO
Stefanie Cavanaugh

Stefanie Cavanaugh

CFO
Christopher J. Gostout

Christopher J. Gostout

Chief Medical Officer
Bret Schwartzhoff

Bret Schwartzhoff

Vice President, US Sales and Global Marketing
Mike Gutteridge

Mike Gutteridge

Vice President, International Sales and Marketing
Laura LeBoeuf

Laura LeBoeuf

Vice President, Quality, Regulatory, and Clinical Affairs
Show more

Apollo Endosurgery Office Locations

Apollo Endosurgery has an office in Austin
Austin, US (HQ)
300 1120 S Capital of Texas Hwy
Show all (1)
Report incorrect company information

Apollo Endosurgery Financials and Metrics

Summary Metrics

Founding Date

2006

Apollo Endosurgery total Funding

$186.8 m

Apollo Endosurgery latest funding size

$22 m

Time since last funding

3 years ago

Apollo Endosurgery investors

Apollo Endosurgery's latest funding round in November 2015 was reported to be $22 m. In total, Apollo Endosurgery has raised $186.8 m
Show all financial metrics

Apollo Endosurgery Revenue

Embed Graph
Apollo Endosurgery's revenue was reported to be $64.31 m in FY, 2017
USD

Revenue (Q2, 2018)

31.5m

Gross profit (Q2, 2018)

18.4m

Gross profit margin (Q2, 2018), %

58.3%

Net income (Q2, 2018)

(17.7m)

EBIT (Q2, 2018)

(15.1m)

Cash (30-Jun-2018)

34.4m
Annual
USDFY, 2016FY, 2017

Revenue

64.9m64.3m

Cost of goods sold

25.3m24.6m

Gross profit

39.6m39.7m

Gross profit Margin, %

61%62%
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

1.3m1.1m783.9k747.6k61.3k9.6k9.2k23.8k14.6m15.7m31.5m

Cost of goods sold

5.1m6.6m13.2m

Gross profit

9.5m9.2m18.4m

Gross profit Margin, %

65%58%58%
Annual
USDFY, 2016FY, 2017

Cash

19.1m30.5m

Accounts Receivable

10.5m

Inventories

12.2m14.3m

Current Assets

43.6m57.6m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2018

Cash

14.3m20.5m12.7m11.9m11.6m7.0m4.7m3.3m8.3m34.4m

Accounts Receivable

1.3m2.1m1.4m731.9k56.0k9.6k9.2k24.9k

Inventories

11.7m15.0m

Current Assets

16.0m24.2m14.5m12.9m11.8m7.3m5.3m4.0m32.1m62.1m
Annual
USDFY, 2016FY, 2017

Net Income

(41.2m)(27.3m)

Depreciation and Amortization

7.2m9.7m

Inventories

(3.1m)(2.8m)

Accounts Payable

523.0k4.7m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(3.7m)(3.2m)(2.8m)(2.6m)(2.2m)(1.9m)(2.7m)(3.7m)(8.2m)(8.1m)(17.7m)

Depreciation and Amortization

1.8m2.4m4.7m

Inventories

(1.2m)(1.0m)

Accounts Payable

2.5m2.6m2.0m1.7m1.2m431.1k462.7k894.6k6.4m272.0k(3.7m)
USDY, 2018

Revenue/Employee

128.9k

Financial Leverage

2 x
Show all financial metrics
Report incorrect company information

Apollo Endosurgery Online and Social Media Presence

Embed Graph
Report incorrect company information

Apollo Endosurgery News and Updates

Global Intragastric Balloons Market 2018-2022 - Key Vendors are Allurion Technologies, Apollo Endosurgery, Helioscopie, Obalon Therapeutics, ReShape Lifesciences & Spatz FGIA

DUBLIN, Sept. 26, 2018 /PRNewswire/ -- The "Global Intragastric Balloons Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Intragastric Balloons Market to grow at a CAGR of 25.18% during the period 2018-2022. The report has been prepared based on an...
Report incorrect company information

Apollo Endosurgery Blogs

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

Dateline City: AUSTIN, Texas AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced toda…

Apollo Endosurgery Completes Enrollment for the ORBERA Post Approval Study

Dateline City: AUSTIN, Texas AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announce…

Apollo Endosurgery and Istituto Clinico Humanitas in Milano, Italy Establish European Registry for Flexible Endoscopic Suturing Procedures in Gastrointestinal Applications

Dateline City: AUSTIN, Texas AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced toda…

Apollo Endosurgery August 2018 Presentation

File: APEN_Aug_2018_Presentation.pdf (1.89 MB) Related Materials Webcast Presentation Language: English

Latest Earnings Release

File: Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results (370.77 KB) Language: English

10-Q Quarterly Report

File: Apollo Endosurgery, Inc Form 10-Q for the quarterly period ended June 30, 2018 (722.41 KB) Language: English
Show more

Apollo Endosurgery Company Life and Culture

Report incorrect company information